BioLife Solutions EBITDA Margin 2010-2024 | BLFS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for BioLife Solutions (BLFS) over the last 10 years. The current EBITDA margin for BioLife Solutions as of December 31, 2024 is .
| BioLife Solutions EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-12-31 |
$0.08B |
$0.00B |
2.41% |
| 2024-09-30 |
$0.08B |
$0.01B |
15.79% |
| 2024-06-30 |
$0.07B |
$0.00B |
-1.45% |
| 2024-03-31 |
$0.07B |
$-0.01B |
-11.43% |
| 2023-12-31 |
$0.08B |
$-0.01B |
-13.16% |
| 2023-09-30 |
$0.05B |
$0.07B |
130.00% |
| 2023-06-30 |
$0.07B |
$0.07B |
104.48% |
| 2023-03-31 |
$0.08B |
$0.01B |
6.33% |
| 2022-12-31 |
$0.08B |
$0.01B |
15.58% |
| 2022-09-30 |
$0.16B |
$-0.10B |
-61.94% |
| 2022-06-30 |
$0.15B |
$-0.10B |
-64.86% |
| 2022-03-31 |
$0.14B |
$-0.03B |
-18.84% |
| 2021-12-31 |
$0.12B |
$-0.02B |
-18.49% |
| 2021-09-30 |
$0.10B |
$-0.01B |
-12.37% |
| 2021-06-30 |
$0.07B |
$-0.01B |
-6.76% |
| 2021-03-31 |
$0.05B |
$0.00B |
-3.77% |
| 2020-12-31 |
$0.05B |
$0.00B |
-4.17% |
| 2020-09-30 |
$0.04B |
$0.00B |
4.88% |
| 2020-06-30 |
$0.04B |
$0.00B |
5.41% |
| 2020-03-31 |
$0.03B |
$0.00B |
5.88% |
| 2019-12-31 |
$0.03B |
$0.00B |
7.14% |
| 2019-09-30 |
$0.03B |
$0.00B |
12.00% |
| 2019-06-30 |
$0.02B |
$0.00B |
17.39% |
| 2019-03-31 |
$0.02B |
$0.00B |
19.05% |
| 2018-12-31 |
$0.02B |
$0.00B |
15.79% |
| 2018-09-30 |
$0.02B |
$0.00B |
11.76% |
| 2018-06-30 |
$0.02B |
$0.00B |
6.67% |
| 2018-03-31 |
$0.01B |
0 |
0.00% |
| 2017-12-31 |
$0.01B |
0 |
0.00% |
| 2017-09-30 |
$0.01B |
0 |
0.00% |
| 2017-06-30 |
$0.01B |
$0.00B |
-11.11% |
| 2017-03-31 |
$0.01B |
$0.00B |
-25.00% |
| 2016-12-31 |
$0.01B |
$0.00B |
-37.50% |
| 2016-09-30 |
$0.01B |
$0.00B |
-50.00% |
| 2016-06-30 |
$0.01B |
$0.00B |
-50.00% |
| 2016-03-31 |
$0.01B |
$0.00B |
-57.14% |
| 2015-12-31 |
$0.01B |
$0.00B |
-57.14% |
| 2015-09-30 |
$0.01B |
$0.00B |
-57.14% |
| 2015-06-30 |
$0.01B |
$0.00B |
-66.67% |
| 2015-03-31 |
$0.01B |
$0.00B |
-66.67% |
| 2014-12-31 |
$0.01B |
$0.00B |
-50.00% |
| 2014-09-30 |
$0.01B |
$0.00B |
-33.33% |
| 2014-06-30 |
$0.01B |
$0.00B |
-14.29% |
| 2014-03-31 |
$0.01B |
0 |
0.00% |
| 2013-12-31 |
$0.01B |
0 |
0.00% |
| 2013-09-30 |
$0.01B |
0 |
0.00% |
| 2013-06-30 |
$0.01B |
0 |
0.00% |
| 2013-03-31 |
$0.01B |
0 |
0.00% |
| 2012-12-31 |
$0.01B |
0 |
0.00% |
| 2012-09-30 |
$0.01B |
0 |
0.00% |
| 2012-06-30 |
$0.00B |
0 |
0.00% |
| 2012-03-31 |
$0.00B |
0 |
0.00% |
| 2011-12-31 |
$0.00B |
0 |
0.00% |
| 2011-09-30 |
$0.00B |
0 |
0.00% |
| 2011-06-30 |
$0.00B |
0 |
0.00% |
| 2011-03-31 |
$0.00B |
0 |
0.00% |
| 2010-12-31 |
$0.00B |
0 |
0.00% |
| 2010-09-30 |
$0.00B |
0 |
0.00% |
| 2010-06-30 |
$0.00B |
0 |
0.00% |
| 2010-03-31 |
$0.00B |
$0.00B |
-100.00% |
| 2009-12-31 |
$0.00B |
$0.00B |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$1.200B |
$0.082B |
|
BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.
|
